Aurobindo Pharma Limited (AUROPHARMA.BO)
INR 1096.8
(0.16%)
INR 1096.8
(0.16%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 21.34 Billion INR | 127.0% |
| 2022 | 9.4 Billion INR | 65.63% |
| 2021 | 5.67 Billion INR | 30.63% |
| 2020 | 4.34 Billion INR | 64.4% |
| 2019 | 2.64 Billion INR | 46.94% |
| 2018 | 1.79 Billion INR | -60.12% |
| 2017 | 4.51 Billion INR | 148.73% |
| 2016 | 1.81 Billion INR | -75.58% |
| 2015 | 7.42 Billion INR | -43.35% |
| 2014 | 13.11 Billion INR | 2.48% |
| 2013 | 12.79 Billion INR | 11.42% |
| 2012 | 11.48 Billion INR | 19.04% |
| 2011 | 9.64 Billion INR | 84.32% |
| 2010 | 5.23 Billion INR | -75.71% |
| 2009 | 21.54 Billion INR | -7.65% |
| 2008 | 23.32 Billion INR | 22.25% |
| 2007 | 19.08 Billion INR | -8.17% |
| 2006 | 20.78 Billion INR | 51.35% |
| 2005 | 13.73 Billion INR | 32.79% |
| 2004 | 10.34 Billion INR | 25.63% |
| 2003 | 8.23 Billion INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 20.29 Billion INR | 0.0% |
| 2023 Q4 | 21.34 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 21.34 Billion INR | 127.0% |
| 2022 FY | 9.4 Billion INR | 65.63% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 6.11 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 9.4 Billion INR | 0.0% |
| 2021 Q4 | 5.67 Billion INR | 0.0% |
| 2021 FY | 5.67 Billion INR | 30.63% |
| 2021 Q2 | 5.19 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q4 | 4.34 Billion INR | 0.0% |
| 2020 FY | 4.34 Billion INR | 64.4% |
| 2020 Q2 | 2.46 Billion INR | 0.0% |
| 2019 Q2 | 3.29 Billion INR | 0.0% |
| 2019 FY | 2.64 Billion INR | 46.94% |
| 2019 Q4 | 2.64 Billion INR | 0.0% |
| 2018 FY | 1.79 Billion INR | -60.12% |
| 2018 Q2 | 2.76 Billion INR | 0.0% |
| 2018 Q4 | 1.79 Billion INR | 0.0% |
| 2017 Q4 | 4.51 Billion INR | 0.0% |
| 2017 FY | 4.51 Billion INR | 148.73% |
| 2017 Q2 | 567 Million INR | 0.0% |
| 2016 FY | 1.81 Billion INR | -75.58% |
| 2016 Q2 | 4.62 Billion INR | 0.0% |
| 2016 Q4 | 1.81 Billion INR | 0.0% |
| 2015 Q2 | 12.36 Billion INR | 0.0% |
| 2015 Q4 | 7.42 Billion INR | 0.0% |
| 2015 FY | 7.42 Billion INR | -43.35% |
| 2014 Q2 | 14.07 Billion INR | 0.0% |
| 2014 Q4 | 13.11 Billion INR | 0.0% |
| 2014 FY | 13.11 Billion INR | 2.48% |
| 2013 Q2 | 11.94 Billion INR | 0.0% |
| 2013 Q4 | 12.79 Billion INR | 0.0% |
| 2013 FY | 12.79 Billion INR | 11.42% |
| 2012 Q4 | 11.48 Billion INR | 0.0% |
| 2012 FY | 11.48 Billion INR | 19.04% |
| 2011 Q4 | 9.64 Billion INR | 0.0% |
| 2011 FY | 9.64 Billion INR | 84.32% |
| 2010 FY | 5.23 Billion INR | -75.71% |
| 2009 FY | 21.54 Billion INR | -7.65% |
| 2008 FY | 23.32 Billion INR | 22.25% |
| 2007 FY | 19.08 Billion INR | -8.17% |
| 2006 FY | 20.78 Billion INR | 51.35% |
| 2005 FY | 13.73 Billion INR | 32.79% |
| 2004 FY | 10.34 Billion INR | 25.63% |
| 2003 FY | 8.23 Billion INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -3295.197% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -14363.112% |
| Granules India Limited | 689.71 Million INR | -2995.359% |
| Indoco Remedies Limited | 3.51 Billion INR | -506.971% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 235.2 Million INR | -8976.956% |
| Alkem Laboratories Limited | 400 Million INR | -5237.25% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Brooks Laboratories Limited | 3.56 Million INR | -598749.93% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -76595.646% |
| Bajaj HealthCare Limited | 650.34 Million INR | -3182.719% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -5898.224% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | -256.411% |
| Eris Lifesciences Limited | 6.54 Billion INR | -226.184% |
| FDC Limited | 2.46 Million INR | -865633.982% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | -1307.401% |
| Gufic Biosciences Limited | 1.53 Billion INR | -1286.631% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -19025.473% |
| Ipca Laboratories Limited | 5.8 Billion INR | -267.826% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -28150.629% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | -1063.433% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Laurus Labs Limited | 8.6 Billion INR | -148.132% |
| Lupin Limited | 1.55 Billion INR | -1274.871% |
| Mankind Pharma Limited | 248.67 Million INR | -8485.032% |
| Medicamen Biotech Limited | 12.55 Million INR | -169943.807% |
| Medico Remedies Limited | 8.67 Million INR | -246083.118% |
| Megasoft Limited | 1.35 Billion INR | -1473.17% |
| NATCO Pharma Limited | 53 Million INR | -40181.132% |
| Piramal Pharma Limited | 24.83 Billion INR | 14.045% |
| RPG Life Sciences Limited | -30.3 Million INR | 70558.746% |
| Sigachi Industries Limited | 265.79 Million INR | -7932.039% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -160418.797% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -9953.401% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 1751453.568% |
| Unichem Laboratories Limited | 382.22 Million INR | -5485.512% |
| Wanbury Limited | 820 Million INR | -2503.537% |
| Windlas Biotech Limited | 20.18 Million INR | -105692.864% |
| ZIM Laboratories Limited | 356 Million INR | -5896.809% |
| Zydus Lifesciences Limited | 251 Million INR | -8405.578% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -19927.205% |
| Divi's Laboratories Limited | 20 Million INR | -106645.0% |
| Hester Biosciences Limited | 1.81 Billion INR | -1074.487% |
| Procter & Gamble Health Limited | 68.8 Million INR | -30930.523% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -152742.211% |
| Bal Pharma Limited | 363.82 Million INR | -5767.947% |
| Strides Pharma Science Limited | 6.71 Billion INR | -217.93% |
| Venus Remedies Limited | 386.8 Million INR | -5419.39% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -5337150.0% |
| Nectar Lifesciences Limited | 1.4 Billion INR | -1421.574% |
| Shilpa Medicare Limited | 5.6 Billion INR | -281.123% |
| Aarti Drugs Limited | 2.75 Billion INR | -675.397% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Ind-Swift Limited | 10.09 Billion INR | -111.48% |
| Valiant Laboratories Limited | 746.63 Million INR | -2759.381% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -8930.88% |
| Solara Active Pharma Sciences Limited | 1.05 Billion INR | -1917.292% |
| Themis Medicare Limited | 267.74 Million INR | -7873.781% |
| Hikal Limited | 4.22 Billion INR | -404.884% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | -33.099% |
| Sequent Scientific Limited | 1.42 Billion INR | -1395.877% |
| Novartis India Limited | 50.7 Million INR | -42008.481% |
| Wockhardt Limited | 8.91 Billion INR | -139.607% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 32.591% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Neuland Laboratories Limited | 449.2 Million INR | -4652.608% |
| Morepen Laboratories Limited | 33.64 Million INR | -63363.139% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -15886.85% |